Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,697,362
+$1,264,352 QoQ
Shares Held
213,597
+9.1% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 311 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. AMRX ranks #11 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HLN
Haleon plc
 2,604,559 $24,300,533
2 BCRX
Biocryst Pharmaceuticals Inc
 1,826,234 $18,262,340
3 ZTS
Zoetis Inc.
 252,429 $18,139,545
4 VTRS
Viatris Inc
 924,858 $14,686,743
5 TAK
Takeda Pharmaceutical Co Ltd
 722,863 $11,587,493
6 ELAN
Elanco Animal Health Inc
 317,401 $7,811,236
7 HROW
Harrow, Inc.
 180,893 $7,682,525
8 TEVA
Teva Pharmaceutical Industries Ltd
 198,546 $6,726,737

All Filings in AMRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,697,362 213,597
2026-03-31 $2,433,010 195,737
2025-12-31 $2,372,983 188,332
2025-09-30 $1,903,740 190,184
2025-06-30 $1,532,293 189,406
2025-03-31 $1,591,395 189,904
2024-12-31 $1,492,436 188,439
2024-09-30 $1,565,007 188,102
2024-06-30 $1,196,847 188,480
2024-03-31 $1,139,891 188,101
2023-12-31 $1,121,523 184,765
2023-09-30 $783,569 185,680
2023-06-30 $454,075 146,476
2023-03-31 $202,959 146,014
2022-12-31 $279,025 140,214
2022-09-30 $282,735 139,968
2022-06-30 $409,310 128,714
2022-03-31 $522,596 125,323
2021-12-31 $420,466 87,780
2021-09-30 $106,068 19,863